1-2 of 2
Keywords: Transfusion
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Survival after Gastrointestinal Bleeding in a New-Onset Heyde’s Syndrome Patient Treated with Multiple Endoscopic Hemostatic Procedures and Repeated Transfusions after Aortic Valve Replacement

Open Access
Subject Area:
Gastroenterology
Genso Notoya, Ryota Niikura, Atsuo Yamada, Masanori Ochi, Takashi Kawai, Kazuhiko Koike
Journal: Case Reports in Gastroenterology
Case Rep Gastroenterol (2022) 15 (3): 819–824.
https://doi.org/10.1159/000519004
Published Online: 23 September 2021
...-assisted endoscopy) and repeated transfusions (total of 394 units of red blood cells). The intensive treatment contributed to the survival time of 10 years. In addition, we performed a literature review of the prognosis of patients with Heyde’s syndrome. [email protected] 12 07 2021...
View articletitled, Long Survival after Gastrointestinal Bleeding in a New-Onset Heyde’s Syndrome Patient Treated with Multiple Endoscopic Hemostatic Procedures and Repeated Transfusions after Aortic Valve Replacement
Open the PDF for Long Survival after Gastrointestinal Bleeding in a New-Onset Heyde’s Syndrome Patient Treated with Multiple Endoscopic Hemostatic Procedures and Repeated Transfusions after Aortic Valve Replacement in another window
Journal Articles

Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension

Open Access
Subject Area:
Gastroenterology
Luigi F. Bertoli, Pauline L. Lee, Lauren Lallone, James C. Barton
Journal: Case Reports in Gastroenterology
Case Rep Gastroenterol (2017) 11 (2): 293–304.
https://doi.org/10.1159/000475748
Published Online: 17 May 2017
..., and portal hypertension with intravenous bevacizumab 2.5 mg/kg every 2 weeks. We tabulated these measures weekly during weeks 1–33 (no bevacizumab); 34–57 (bevacizumab); and 58–97 (no bevacizumab): hemoglobin (Hb) levels; platelet counts; units of transfused packed erythrocytes (PRBC units); and quantities...
View articletitled, Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension
Open the PDF for Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension in another window